Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04841551 · ClinicalTrials.gov registry record · Phase 4
Kybella for the Treatment of Flank Fat (FF)
A Phase 4 study of Adiposity, sponsored by Beer, Kenneth R., M.D., PA.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04841551: Completed Phase 4 study of Adiposity, sponsored by Beer, Kenneth R., M.D., PA.
NCT04841551 is a Phase 4 study of Adiposity that has completed, run by Beer, Kenneth R., M.D., PA. The registered enrollment target is 10 participants, below the 100-participant average among 11 other Adiposity trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04841551, a Phase 4 study of Adiposity, has completed, sponsored by Beer, Kenneth R., M.D., PA.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
To Determine the safety and Effectiveness of Kybella for the treatment of Flank Fat (FF)
Primary Outcome
The change in the appearance and rating of the flank fat through MRI study and as measured by the independent observer GAIS rating. Change in the Global Aesthetic Improvement Scale (GAIS) as measured by the principal investigator. The investigator will independently assess the subject's level of improvement on the GAIS scale, comparing the live subject with his/her pre-treatment digital image, at all follow-up visits. 5-Point Global Aestheic Improvement Scale (GAIS) Score Grade Description 2 Mu
Conditions Studied
Interventions
- DRUG Kybella Flanks
Study Locations (1)
Florida
- Kenneth Beer, MD, PA - West Palm Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-07-22 |
| Est. Completion | 2022-03-02 |
| Phase | Phase 4 |
What the finished NCT04841551 record still lists
NCT04841551 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 100-participant average among 11 other Adiposity trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Adiposity appearing as the primary indexed condition, and to 1 intervention - of which Kybella Flanks is the first listed.
NCT04841551 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04841551 about?
NCT04841551 is a clinical study titled "Kybella for the Treatment of Flank Fat (FF)". To Determine the safety and Effectiveness of Kybella for the treatment of Flank Fat (FF)
What is the current status of trial NCT04841551?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2021-07-22. Estimated completion is 2022-03-02.
What conditions does trial NCT04841551 study?
This clinical trial studies the following conditions: Adiposity.
What interventions are being tested in trial NCT04841551?
The interventions under investigation include: Kybella Flanks (DRUG).
Who is sponsoring clinical trial NCT04841551?
This trial is sponsored by Beer, Kenneth R., M.D., PA, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04841551 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adiposity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04841551's enrollment target sits among peer trials
10 11th of 11 higher than 1 of 11 other Adiposity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adiposity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cardiometabolic Consequences of the Loss of Ovarian Function
RECRUITING · Phase 4
-
Kybella With Triamcinolone
COMPLETED · Phase 4
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Redefining BMI: The Body, Mind, and Inflammation Trial
RECRUITING · NA
-
The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI